PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187906. A total of 2 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $152,000 | -74.8% | 361 | -73.9% | 0.01% | -73.3% |
| Q1 2016 | $603,000 | +17.1% | 1,384 | +64.8% | 0.03% | +7.1% |
| Q4 2015 | $515,000 | +7.3% | 840 | 0.0% | 0.03% | +40.0% |
| Q3 2015 | $480,000 | +5.7% | 840 | +37.9% | 0.02% | +17.6% |
| Q2 2015 | $454,000 | +115.2% | 609 | +24.3% | 0.02% | +88.9% |
| Q2 2014 | $211,000 | -34.9% | 490 | -38.3% | 0.01% | -50.0% |
| Q1 2014 | $324,000 | – | 794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 47,400 | $300,000 | 0.00% |
| SIMPLEX TRADING, LLC | 49 | $1,000 | 0.00% |